Related Experiment Video

Updated: Mar 8, 2026

Author Spotlight: Integrating Traditional Chinese Medicine with Modern Pharmacology and Genomics for Assessing Postmenopausal Osteoporosis in Mice
07:20

Author Spotlight: Integrating Traditional Chinese Medicine with Modern Pharmacology and Genomics for Assessing Postmenopausal Osteoporosis in Mice

Published on: August 23, 2024

1.1K

Novel Therapies for Postmenopausal Osteoporosis

Leonardo Bandeira1, John P Bilezikian1

  • 1Department of Medicine, College of Physicians and Surgeons, Columbia University, 630 West 168th Street, PH8W-864, New York, NY 10032, USA.

Endocrinology and Metabolism Clinics of North America
|January 30, 2017
PubMed

Insights

New osteoporosis therapies are emerging from recently discovered mechanisms, particularly for postmenopausal osteoporosis. Research continues to advance treatment options for this bone condition.

Area of Science:

  • Bone biology and pharmacology
  • Endocrinology
  • Gerontology

Background:

  • Osteoporosis is a significant health concern, especially in postmenopausal women.
  • Current therapeutic strategies have improved but are not universally effective.
  • Understanding disease mechanisms is key to developing novel treatments.

Purpose of the Study:

  • To review recent advances in osteoporosis therapy.
  • To highlight newly developed drug classes for postmenopausal osteoporosis.
  • To emphasize the ongoing need for innovative osteoporosis treatments.

Main Methods:

  • Literature review of recent discoveries in osteoporosis mechanisms.
  • Analysis of newly developed therapeutic agents.
  • Synthesis of current advancements in osteoporosis treatment.

Main Results:

  • Novel therapeutic targets have been identified through recent mechanistic discoveries.
  • New drug classes show promise for treating postmenopausal osteoporosis.
  • Significant progress has been made over the last two decades.

Conclusions:

  • Recent mechanistic insights are driving the development of advanced osteoporosis therapies.
  • New drug classes offer improved treatment options for postmenopausal osteoporosis.
  • Continued research is essential to address unmet needs in osteoporosis management.
Keywords:
AntiresorptiveOsteoanabolicOsteoporosisPostmenopausalTherapeutics

More Related Videos

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders11:47

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders

Published on: June 8, 2014

12.2K
Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats08:56

Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats

Published on: April 7, 2023

1.3K

Related Concept Videos

Menopause01:28

Menopause

Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
5.1K
Bone Remodeling01:40

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
40.8K
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
4.5K
Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
5.8K
Hormonal Control of the Ovarian Cycle01:30

Hormonal Control of the Ovarian Cycle

The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle.  At puberty, GnRH secretion increases in both frequency and...
7.3K
Role of Vitamins in Maintaining Bone Health01:25

Role of Vitamins in Maintaining Bone Health

The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
5.9K